Kaya, BugraDostbil, ZekiIsmailoglu, MuratTasdemir, BekirSahin, Ozlem2024-04-242024-04-2420150899-70711873-4499https://doi.org/10.1016/j.clinimag.2015.02.006https://hdl.handle.net/11468/15254Aim: We aimed to investigate the impact of chemotherapy on F-18-FDG uptake in the liver and mediastinal blood pool (MBP) among patients with non-Hodgkin's lymphoma. Methods: Twenty-three patients with NHL underwent baseline, interim, and postchemotherapy F-18-FDG PET/CT. SUVmax and SUVmean values of the liver and MBP at imaging time were compared statistically. Results: We did not find any significant differences between the liver and mediastinum SUVmean and SUVmax values (P>.05). Conclusions: Our study demonstrates that the F-18-FOG uptake in the liver and MBP are not significantly affected by R-CHOP chemotherapy in patients with NHL. (C) 2015 Elsevier Inc. All rights reserved.eninfo:eu-repo/semantics/closedAccessPetNon-Hodgkin's LymphomaChemotherapyR-ChopStandardized Uptake ValueArticle394632635WOS:0003569063000172-s2.0-849541979312570911210.1016/j.clinimag.2015.02.006Q2Q4